Literature DB >> 22270434

Raynaud's phenomenon of the nipple.

Mae Wu1, Rebecca Chason, Michelle Wong.   

Abstract

BACKGROUND: Raynaud's phenomenon is a well-described pathologic state in which there is episodic vasospasm followed by vasodilation. It is described most commonly in the digits but also has been shown to affect the nipple vasculature. Raynaud's phenomenon of the nipple may result in discontinuation of breastfeeding secondary to pain and disruption of the maternal-infant bonding process. CASES: We present the cases of two patients with painful breastfeeding associated with color changes of the nipple. Owing to a clinical presentation similar to fungal infections, the patients were treated repeatedly with antifungals before the correct diagnosis was made. Symptoms resolved with a course of nifedipine.
CONCLUSION: Increased awareness in the obstetric field will lead to appropriate diagnoses, earlier treatment and relief, and more successful breastfeeding experiences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270434     DOI: 10.1097/AOG.0b013e31822c9a73

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Nipple pain, damage, and vasospasm in the first 8 weeks postpartum.

Authors:  Miranda L Buck; Lisa H Amir; Meabh Cullinane; Susan M Donath
Journal:  Breastfeed Med       Date:  2013-12-31       Impact factor: 1.817

2.  Postpartum Nipple Symptoms: Risk Factors and Dermatologic Characterization.

Authors:  Leah Laageide; Stephanie Radke; Donna Santillan; Patrick Ten Eyck; Jennifer Powers
Journal:  Breastfeed Med       Date:  2020-12-18       Impact factor: 1.817

3.  Glomus Tumor Presenting as Raynaud's Phenomenon.

Authors:  M H Abdelrahman; M Hammoudeh
Journal:  Case Rep Med       Date:  2012-06-28

4.  Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres.

Authors:  Jan Anker Jahnsen; Sofia Frost Widnes; Jan Schjøtt
Journal:  Int Breastfeed J       Date:  2018-01-09       Impact factor: 3.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.